References
- Fasola FA, Eteng KI, Shokunbi WA, Akinyemi JO, Salako BL. Renal status of multiple myeloma patients in Ibadan, Nigeria. Ann Ib Postgrad Med. 2012; 10(2):28-33. PubMed | Google Scholar
- Lifetime risk was calculated by the Statistical Information Team at Cancer Research UK, 201 www.cancerresearchuk.org. PubMed | Google Scholar
- Esteve J, Benhamou E, Raymond L. Descriptive epidemiology
[IARC Scientific Publications No.128] (link is external), p 67-68. Lyon: International
Agency for Research on Cancer; 1994. PubMed | Google
Scholar
- Waller J, Robb K, Stubbings S, Ramirez A, Macleod U, Austoker
J et al. Awareness of cancer symptoms and anticipated help seeking among ethnic
minority groups in England (link is external). Brit J Cancer. 2009; 101Suppl
2:S24-30. PubMed | Google
Scholar
- Robb K, Stubbings S, Ramirez A, Macleod U, Austoker J, Waller J et al. Public awareness of cancer in Britain: a population-based survey of adults. Brit J Cancer. 2009;101Suppl 2:S18-23. PubMed | Google Scholar
- Anetor JI, Ajose FI, Akingbola TS. A Case Of IgA Multiple Myeloma: nutritional perspective in diagnostic testing. Indian J Clin Biochem. 2005; 20 (1) 193-197. PubMed | Google Scholar
- Altekruse SF, Kosary CL, Krapcho M. SEER Cancer Statistics Review, 1975?200 Bethesda: National Cancer Institute; 2010. Google Scholar
- Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY et al. Racial disparities in incidence and outcome in multiple myeloma: a population basedstudy. Blood. 2010; 116: 5501-5506. PubMed | Google Scholar
- Greenberg AJ, Philip S, Paner A, Velinova S, Badros A, Catchatourian R et al. Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-centre study. Blood Cancer J. 2015; 5:e271. Google Scholar
- Fonseca R. Many and multiple myeloma(s). Leukemia. 2003;17:1943-1944. Google Scholar
- Madu AJ, Ocheni S, Nwagha TA, Ibegbulam OG, Anike US. Multiple myeloma in Nigeria: An insight to the clinical, laboratory features, and outcomes. Niger J Clin Pract. 2014 Mar-Apr;17(2):212-7. Google Scholar
- Saad F, Lipton A, Cook R, Chen Y, Smith M, Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007 Oct 15;110(8):1860-7. PubMed | Google Scholar
- Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; 359:1761-1767. PubMed | Google Scholar
- Oyajobi BO. Multiple myeloma/hypercalcemia. Arthritis Research & Therapy. 2007; 9(Suppl 1): S4. PubMed | Google Scholar
- Oyajobi BO, Mundy GR. Pathophysiology of myeloma bone disease. In: Gahrton G, Durie BGM, Samson DS, editor. Multiple Myeloma and Related Disorders. 2. London, UK: Arnold; 2004. pp. 74-88. Google Scholar
- Tuttle KR, Kunau RT, Loveridge N, Mundy GR. Altered renal calcium handling in hypercalcemia of malignancy. J Am Soc Nephrol. 1991 Aug;2(2):191-9. PubMed | Google Scholar
- Sinohara H, Matsuura K. Does catalytic activity of Bence Jones protein contribute to the pathogenesis of multiple myeloma. Appl Biochem Biotechnol. 2000;83(1-3):85-92;discussion 93-4;145-53. PubMed | Google Scholar
- Heher EC, Rennke HG, Laubach JP, Richardson PG. Kidney disease and Multiple myeloma. Clin J Am Soc Nephrol. 2013;8(11):2007-17. PubMed | Google Scholar